AU Stock MarketDetailed Quotes

ALA Arovella Therapeutics Ltd

Watchlist
  • 0.175
  • -0.005-2.78%
20min DelayTrading Dec 3 14:10 AET
185.39MMarket Cap-19444P/E (Static)

Arovella Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Arovella Therapeutics Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/FY405.900K / 379.590K--
--2022/FY295.810K / 1.335M--
--2021/FY257.350K / 485.000K--
--2020/FY532.690K / 740.000K--
DatePeriodRevenue/EstimateEarnings Call
--2023/FY405.900K / 379.590K--
--2022/FY295.810K / 1.335M--
--2021/FY257.350K / 485.000K--
--2020/FY532.690K / 740.000K--
--------

Unlock Free Earnings Estimates

Arovella Therapeutics Ltd Earnings Reports

  • Arovella Therapeutics Ltd: Arovella receives R&D tax rebate of $3.0 million

    Oct 25 07:55

  • Arovella Therapeutics Ltd: Appendix 4E and Annual Report

    Aug 22 07:43

  • Arovella Therapeutics Ltd: Appendix 4D and Half Year Report

    Feb 28 09:43

  • Arovella Therapeutics Ltd: Appendix 4E and Annual Report

    Aug 31, 2023 08:16

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    AU
    Overall
    Symbol
    Latest Price
    % Chg

    No Data